معرفی
Balveen Kaur is Associate Director of Basic Science and Professor at the Medical College of Georgia, Augusta University. Her academic appointments span the Department of Pathology and Georgia Cancer Center, with a focus on oncolytic virotherapy and glioblastoma research.
- Ph.D., Biomedical Sciences, Emory University (1999)
- B.S., Biotechnology, University of Delhi (1990)
Her research centers on oncolytic herpesvirus therapy, tumor-immune interactions, and signal transduction in glioblastoma multiforme and breast cancer brain metastasis. She investigates metabolic reprogramming, immunosuppressive pathway inhibition (e.g., IDO, IGF2-IGF1R), and the role of stromal cells in tumor progression. Her work often combines viral engineering with pharmacological and immunotherapeutic approaches to overcome treatment resistance.
The 2025-2024 articles highlight her leadership in HSV-1 strain development, Notch and CD73 signaling, and multi-drug synergy for glioblastoma. Publications emphasize metabolic-immune crosstalk (reductive carboxylation, ferroptosis), bi-specific antibodies penetrating the blood-brain barrier, and targeted stromal modulation in pancreatic and ovarian cancers. These span disciplines like Virology, Cancer Biology, and Immunology, with subfields including tumor microenvironment engineering, epigenetic drug interactions, and neuro-immuno-oncology.
- Ande Leon and Dorothy Bloom Distinguished Chair in Cancer Research (2023)
She chairs the GCC Research Retreat and MOI Career Development committee, and serves on the American Society for Cell and Gene Therapy meetings. Her work includes collaborations with UGA Cancer Center and translational applications in remote heart failure monitoring systems (TCC-HF).
